Immunotherapy for cancer patients with COVID-19 appears safe, a preliminary study suggests.
This form of treatment activates a person's immune system against cancer.
Researchers have been wary, because many COVID-19 complications result from an overactive immune response that leads to increased production of proteins called cytokines that can cause issues such as respiratory failure.
/University Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
